InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 07/31/2017

Re: Ej23ny post# 11166

Saturday, 11/02/2019 1:24:15 PM

Saturday, November 02, 2019 1:24:15 PM

Post# of 18220
You are misrepresenting/misinforming others in a public forum. You clearly stated to me in post #11162 that "You are missing the big picture Imun - has acquired exclusive rights to naltrexone". That definitively infers that IMUN has exclisuive rights to all regarding naltrexone. That is not a correct statement and is misleading! In response to my request you send a link dated back to 2013 wherein an announcement was issed by IMUN regarding the exclusive licensing rights garnered by IMUN to Penn State Universitry and separate Jill Smith, M.D, patents for the use of Low Dose Naltrexone (LDN) in the treatment of specific disease entities-period-that is all the exclusivity.